Bg pattern

COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml eye drops solution

Tetracaine hydrochloride/Oxybuprocaine hydrochloride

Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.

  • Keep this package leaflet, as you may need to read it again.
  • If you have any questions, consult your doctor or pharmacist.
  • This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What COLIROFTA ANESTHETIC DOUBLE is and what it is used for
  2. What you need to know before starting to use COLIROFTA ANESTHETIC DOUBLE
  3. How to use COLIROFTA ANESTHETIC DOUBLE
  4. Possible side effects

5 Conservation of COLIROFTA ANESTHETIC DOUBLE

  1. Contents of the pack and additional information

1. What COLIROFTA ANESTHETIC DOUBLE is and what it is used for

It is an eye drop that contains two active ingredients, tetracaine and oxybuprocaine, which are local anesthetics (medicines that temporarily remove sensitivity at the site of administration).

Colirofta Anesthetic Double is indicated for painful conditions of the eye, minor eye surgery (short ophthalmological procedures), and during and after the removal of foreign bodies.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before starting to use COLIROFTA ANESTHETIC DOUBLE

Do not use Colirofta Anesthetic Double

If you are allergic to oxybuprocaine, tetracaine, or local anesthetics of the same type derived from para-aminobenzoic acid, or to any of the other components of this medication (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before starting to use Colirofta Anesthetic Double.

  • Use this medication only in the eye(s).
  • Repeated use of this medication can cause corneal ulcers.
  • Prolonged use of one of the components, tetracaine, can lead to decreased duration of anesthesia and delayed healing, among other visual side effects.
  • Due to the effect of anesthetics, your eyes will lose sensitivity, and you should be careful to avoid accidental injuries to the eyes.
  • It should be used with caution if you have heart disease or hyperthyroidism.
  • This medication should only be used under the direct supervision of a healthcare professional.

Use in elderly patients

See section 3.

Children

The efficacy and safety of this medication have not been established in children.

Other medications and Colirofta Anesthetic Double

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

Especially consult your doctor if you are using:

  • Sulfonamides in eye drops or ointment.
  • St. John's Wort (may cause a drop in blood pressure).

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

You should not use Colirofta Anesthetic Double during pregnancy.

If you are breastfeeding, consult your doctor, who will decide whether to interrupt breastfeeding or treatment after considering the benefits and risks.

Driving and using machines

You may notice that your vision becomes blurry for a while after applying the eye drops. Do not drive or use machines until this effect has disappeared.

Colirofta Anesthetic Double contains phosphates

This medication contains 10.1 mg of phosphates per ml.

If you have severe corneal damage (the transparent layer on the front of the eye), treatment with phosphates, in very rare cases, can cause blurry vision due to calcium accumulation.

3. How to use COLIROFTA ANESTHETIC DOUBLE

Follow the administration instructions for this medication exactly as indicated by your doctor. If you have any doubts, consult your doctor or pharmacist again.

The normal dose is:

Adults

Usually, instill 1 or 2 drops in the affected eye as needed.

Use in children

The safety and efficacy of this medication have not been established in children.

Use in elderly patients

It is recommended to start treatment with the lowest recommended dose, as these patients may have a variable response to one of the components of the medication, tetracaine.

Use in case of hepatic and/or renal insufficiency

The safety and efficacy of this medication have not been established in patients with hepatic and/or renal insufficiency.

Recommendations for use:

Ophthalmic route (in the eye(s)).

Sequence of three steps showing application of eye drops, person looking up and tilting head back

1 2 3

  1. Wash your hands.
  2. Take the bottle (dropper).
  3. After opening the bottle for the first time, remove the plastic ring from the seal.
  4. Hold the bottle, upside down, between your fingers.
  5. Tilt your head back. Gently separate the eyelid from the eye with a finger until a pouch forms, where the drop should fall (figure 1).
  6. Bring the tip of the bottle close to the eye. You may find it helpful to use a mirror.
  7. Do not touch the eye or eyelid, or nearby areas, with the dropper. The eye drops may become contaminated.
  8. Gently squeeze the base of the bottle to release one drop at a time (figure 2).
  9. After using this eye drop, press the edge of the eye near the nose with your finger. This helps prevent the medication from entering the rest of the body (figure 3).
  10. If you are applying drops to both eyes, repeat all the previous steps with the other eye.
  11. Close the bottle immediately after using the medication.

If a drop falls outside the eye, try again.

If you are using other ophthalmic medications, wait at least 5 minutes between the administration of this eye drop and other ophthalmic medications. Ophthalmic ointments should be administered last.

If you use more COLIROFTA ANESTHETIC DOUBLE than you should

An overdose in the eyes can be eliminated by rinsing the eyes with warm water. Do not apply more drops until the next dose.

In case of severe overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount used.

Severe reactions may occur, affecting the nervous system or cardiovascular system, among others (especially in children).

If you forget to use COLIROFTA ANESTHETIC DOUBLE

Do not apply a double dose to make up for forgotten doses.

Apply a single dose as soon as you remember. However, if it is almost time for the next dose, continue with the next dose of your regular regimen.

If you have any further questions about the use of this medication, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Excessive use of this medication can cause corneal injury or eye damage.

There have been reports of some cases of iris damage and corneal swelling.

In rare cases, allergic reactions may occur.

Reporting side effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaRAM.es.By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Conservation of COLIROFTA ANESTHETIC DOUBLE

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date shown on the packaging and carton after EXP. The expiration date is the last day of the month indicated.

Before opening, store in the refrigerator (between 2°C and 8°C). Once opened, do not store above 25°C.

To avoid infections, the bottle should be discarded 4 weeks after it was first opened.

Write the opening date of the bottle in the space provided on the carton for this purpose.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medication in the SIGRE collection point at the pharmacy. If you have any doubts, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Contents of the pack and additional information

Composition of COLIROFTA ANESTHETIC DOUBLE

  • The active ingredients are tetracaine hydrochloride and oxybuprocaine hydrochloride. Each ml of eye drop solution contains 1 mg of tetracaine hydrochloride (0.1%) and 4 mg of oxybuprocaine hydrochloride (0.4%).
  • The other ingredients are chlorobutanol, potassium dihydrogen phosphate, sodium hydrogen phosphate dodecahydrate, and purified water.

Appearance of the product and contents of the pack

Colirofta Anesthetic Double is an eye drop solution; a clear, colorless, or slightly yellowish liquid.

It is presented in a carton containing a dropper bottle (10 ml plastic bottle).

Marketing authorization holder and manufacturer

Marketing authorization holder

Alcon Healthcare, S.A.

World Trade Center Almeda Park

Plaça de la Pau s/n, Edificio 6, planta 3

08940 – Cornellà de Llobregat (Barcelona)

Spain

Manufacturer

Siegfried El Masnou, S.A.

C/ Camil Fabra, 58

08320 – El Masnou (Barcelona)

Spain

or

Alcon Laboratories Belgium

Lichterveld 3

2870 Puurs-Sint-Amands

Belgium

Date of the last revision of this package leaflet: January 2023

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION

Discuss questions about COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION?
COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION?
The active ingredient in COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION is combinations. This information helps identify medicines with the same composition but different brand names.
Who manufactures COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION?
COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION is manufactured by Alcon Healthcare S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to COLIROFTA ANESTHETIC DOUBLE 1 mg/ml + 4 mg/ml EYE DROPS SOLUTION?
Other medicines with the same active substance (combinations) include COLIROFTA ANESTHETIC 5 mg/ml + 0.5 mg/ml EYE DROPS SOLUTION, OPHTESIC 20 mg/g OPHTHALMIC GEL SINGLE-DOSE CONTAINER, OXIBUPROCAINE HYDROCHLORIDE AGEPHA 4 MG/ML EYE DROPS IN SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media